Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).

被引：0

作者：

Levi, Francis

Boige, Valerie

Hebbar, Mohamed

Smith, Denis

Lepere, Celine

Focan, C. N. J.

Guimbaud, Rosine

Carvalho, Carlos

Tumolo, Salvatore

Innominato, Pasquale F.

Ajavon, Yves

Truant, Stephanie

Castaing, Denis

De Baere, Thierry

Kunstlinger, Francis

Karaboue, Abdoulaye

Bouchahda, Mohamed

Rougier, Philippe R.

Adam, Rene

Ducreux, Michel

机构：

[1] Hop Paul Brousse, INSERM, Dept Med Oncol, U776, Villejuif, France

[2] Inst Gustave Roussy, Serv Hepatogastroenterol, Villejuif, France

[3] Ctr Hosp Reg & Univ Lille, Hop Huriez, Med Oncol Unit, F-59037 Lille, France

[4] Hop St Andre, Bordeaux, France

[5] Hop Europeen Georges Pompidou, Paris, France

[6] CHC Clin St Joseph, Liege, Belgium

[7] Univ Hosp Purpan, Toulouse, France

[8] Hosp Fernando Fonesca, Med Oncol Unit, Amadora, Portugal

[9] S Maria Degli Angeli Gen Hosp, Med Oncolgy Unit, Pordenone, Italy

[10] Hop Paul Brousse, INSERM, U776, Dept Cancerol,Serv Chronotherapie, Villejuif, France

[11] Hop Paul Brousse, Serv Radiol, Villejuif, France

[12] CHU Lille, F-59037 Lille, France

[13] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France

[14] Inst Gustave Roussy, Villejuif, France

[15] Hop Paul Brousse, INSERM, U776, Villejuif, France

[16] European Hosp George Pompidou, Paris, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期

关键词：

D O I：

10.1200/jco.2013.31.4_suppl.466

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

466

引用

页数：1